The role of inflammation in irritable bowel syndrome (IBS)
Authors:
Top Cited Papers
Open Access
- 1 September 2018
- journal article
- review article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 11, 345-349
Abstract
Irritable bowel syndrome (IBS) is a complex, functional gastrointestinal disorder characterized by chronic abdominal pain or discomfort and altered bowel habits. Despite the global prevalence and disease burden of IBS, its underlying pathophysiology remains unclear. Inflammation may play a pathogenic role in IBS. Studies have highlighted the persistence of mucosal inflammation at the microscopic and molecular level in IBS, with increased recruitment of enteroendocrine cells. Substantial overlaps between IBS and inflammatory bowel disease have also been reported. This review thus aimed to discuss the body of evidence pertaining to the presence of mucosal inflammation in IBS, its putative role in the disease process of IBS, and its clinical relevance. Increased mast cell density and activity in the gut may correlate with symptoms of visceral hypersensitivity. As evidenced by patients who develop postinfectious IBS, infective gastroenteritis could cause systemic inflammation and altered microbiome diversity, which in turn perpetuates a cycle of chronic, low-grade, subclinical inflammation. Apart from mucosal inflammation, neuroinflammation is probably involved in the pathophysiology of IBS via the “gut–brain” axis, resulting in altered neuroendocrine pathways and glucocorticoid receptor genes. This gives rise to an overall proinflammatory phenotype and dysregulated hypothalamic–pituitary–adrenal axis and serotonergic (5-HT) functioning, which could, at least in part, account for the symptoms of IBS. Although a definite and reproducible pattern of immune response has yet to be recognized, further research into anti-inflammatories may be of clinical value.Keywords
This publication has 41 references indexed in Scilit:
- Impaired Uptake of Serotonin by Platelets From Patients With Irritable Bowel Syndrome Correlates With Duodenal Immune ActivationGastroenterology, 2011
- Heightened central affective response to visceral sensations of pain and discomfort in IBSNeurogastroenterology & Motility, 2010
- Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI studyGut, 2009
- Dysregulation of the hypothalamic‐pituitary‐adrenal (HPA) axis in irritable bowel syndromeNeurogastroenterology & Motility, 2009
- Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohortBMC Gastroenterology, 2009
- Histopathological alterations in irritable bowel syndromeLaboratory Investigation, 2006
- A Controlled Study of Colonic Immune Activity and β7+ Blood T Lymphocytes in Patients With Irritable Bowel SyndromeClinical Gastroenterology and Hepatology, 2005
- Dyspepsia and Irritable Bowel Syndrome After a Salmonella Gastroenteritis Outbreak: One-Year Follow-up Cohort StudyGastroenterology, 2005
- Is Irritable Bowel Syndrome a Low-Grade Inflammatory Bowel Disease?Gastroenterology Clinics of North America, 2005
- Increased mast cells in the irritable bowel syndromeNeurogastroenterology & Motility, 2000